‘Microprotein’ biotech Velia, backed by TCG and Foresite, to wind down

San Diego-based Velia Ther­a­peu­tics, which was work­ing on so-called mi­cro­pro­teins, is in the process of wind­ing down about two years af­ter a $55 mil­lion Se­ries …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.